Recently, the U.S. Food and Drug Administration issued an alert that it is requesting manufacturers to immediately withdraw all prescriptions and over-the-counter (OTC) ranitidine drugs from the market. This includes the well-known brand, Zantac. The medicines may contain low levels of a nitrosamine impurity called N-nitrosodimethylamine (NDMA), and the FDA has determined that the impurity may increase over time leading to an unacceptable level of consumer exposure.
At GI Associates, patient care and safety is our priority. If you take Zantac, please call us at 601-355-1234. You may also request an appointment through the patient portal.
For ongoing updates from the FDA on NDMA in Zactac, visit their website.
Share
